Augmedix to Announce Second Quarter 2024 Financial Results on August 12, 2024
Rhea-AI Summary
Augmedix (Nasdaq: AUGX), a leading provider of ambient AI medical documentation and data solutions, has announced that it will release its second quarter 2024 financial results after the market closes on Monday, August 12, 2024. The company also disclosed that on July 19, 2024, it entered into a definitive agreement to be acquired by Commure, Inc., a prominent technology provider for healthcare systems. As a result of this pending acquisition, Augmedix management will not be hosting a quarterly conference call to discuss the financial results.
Positive
- Augmedix has entered into a definitive agreement to be acquired by Commure, Inc., potentially strengthening its market position
- The company is maintaining transparency by releasing its Q2 2024 financial results as scheduled
Negative
- Management will not host a quarterly conference call, potentially limiting investor engagement and detailed financial discussions
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, announced today it anticipates releasing second quarter 2024 results after the market closes on Monday, August 12, 2024.
On July 19, 2024, Augmedix announced that it entered into a definitive agreement to be acquired by Commure, Inc., a leading provider of technology to healthcare systems. Due to this pending acquisition, management is not hosting a quarterly conference call.
About Augmedix
Augmedix (Nasdaq: AUGX) empowers clinicians to connect with patients by liberating them from administrative burden through the power of ambient AI, data, and trust. The platform transforms natural conversations into organized medical notes, structured data, and point-of-care notifications that enhance efficiency and clinical decision support. Incorporating data from millions of interactions across all care settings, Augmedix collaborates with hospitals and health systems to improve clinical, operational, and financial outcomes. Augmedix is headquartered in San Francisco, CA, with offices around the world. To learn more, visit www.augmedix.com.
Contact Information
Investors:
Matt Chesler, CFA
FNK IR
(646) 809-2183
augx@fnkir.com
investors@augmedix.com
Media:
Kaila Grafeman
Augmedix
pr@augmedix.com
